Table 2.
All n(%) | Acceptable Swallowing n(%) | Poor Swallowing n(%) | OR Ɨ | 95% CIǂ | |
---|---|---|---|---|---|
Age (years) | |||||
Mean (SD) | 59.4 (9.2) | 58.0 (9.2) | 62.5 (8.3) | 1.06 | 1.00–1.12 |
| |||||
Age (dichotomous) | |||||
Less than 60 | 45 (55) | 34 (61) | 11 (42) | ||
60 or Greater | 37 (45) | 22 (39) | 15 (58) | 2.11 | 0.82–5.42 |
| |||||
Gender | |||||
Male | 74 (90) | 50 (89) | 24 (92) | ||
Female | 8 (10) | 6 (11) | 2 (8) | 0.69 | 0.13–3.70 |
| |||||
Smoking | |||||
Never | 31 (38) | 23 (41) | 8 (30) | ||
Past | 33 (40) | 24 (43) | 9 (35) | 1.08 | 0.36–3.27 |
Current | 18 (22) | 9 (16) | 9 (35) | 2.88 | 0.84–9.79 |
| |||||
Smoking | |||||
Never | 31 (38) | 23 (41) | 8 (31) | ||
Past or Current Smoker | 51 (62) | 33 (59) | 18 (69) | 1.57 | 0.58–4.21 |
| |||||
ACE | |||||
0 (None) | 33 (40) | 24 (43) | 9 (35) | ||
1 (Mild) | 40 (49) | 26 (46) | 14 (54) | 1.44 | 0.53–3.92 |
2 (Moderate) | 7 (9) | 4 (7) | 3 (11) | 2.00 | 0.37–10.75 |
3 (Severe) | 2 (2) | 2 (4) | 0 (0) | NA | NA |
| |||||
ACE | |||||
None | 33 (40) | 24 (43) | 9 (35) | ||
Comorbidities Present | 49 (60) | 32 (57) | 17 (65) | 1.42 | 0.54–3.72 |
| |||||
Site (Consolidated) | |||||
BOT | 42 (51) | 26 (46) | 16 (62) | ||
Tonsil | 40 (49) | 30 (54) | 10 (38) | 0.54 | 0.21–1.40 |
| |||||
Tumor Histology | |||||
Well-differentiated | 0 (0) | 0 (0) | 0 (0) | ||
Moderately differentiated | 9 (11) | 4 (7) | 5 (20) | ||
Poorly differentiated | 16 (20) | 10 (19) | 6 (24) | 0.48 | 0.09–2.52 |
Non-keratinizing | 48 (61) | 36 (67) | 12 (48) | 0.27 | 0.06–1.16 |
Other | 6 (8) | 4 (7) | 2 (8) | 0.40 | 0.05–3.42 |
Missing | 3 | ||||
| |||||
pT Pathologic Tumor Stage (AJCC 7th ed.) | |||||
T3 | 45 (55) | 35 (63) | 10 (38) | ||
T4a, T4b | 37 (45) | 21 (37) | 16 (62) | 2.67 | 1.02–6.95 |
| |||||
pN Pathologic Nodal Stage (AJCC 7th ed.) | |||||
N0 | 12 (15) | 11 (20) | 1 (4) | ||
N1 | 7 (9) | 5 (9) | 2 (8) | 4.40 | 0.32–60.61 |
N2a | 9 (11) | 8 (14) | 1 (4) | 1.38 | 0.07–25.43 |
N2b | 30 (37) | 21 (37) | 9 (36) | 4.71 | 0.53–42.17 |
N2c | 21 (26) | 9 (16) | 12 (48) | 14.67 | 1.59–135.32 |
N3 | 2 (2) | 2 (4) | 0 (0) | NA | NA |
Missing | 1 | ||||
| |||||
pStage Pathologic Stage (AJCC 7th ed.) | |||||
I, II, III | 9 (11) | 8 (15) | 1 (4) | ||
IVA, IVB | 71 (89) | 46 (85) | 25 (96) | 4.35 | 0.51–36.78 |
Missing | 2 | ||||
| |||||
Type of Surgical Treatment | |||||
TLM | 74 (90) | 48 (86) | 26 (100) | ||
TORS | 4 (5) | 4 (7) | 0 (0) | NA | NA |
Loupes | 4 (5) | 4 (7) | 0 (0) | NA | NA |
| |||||
BOT Resection | |||||
0–49% Resection | 53 (65) | 41 (73) | 12 (46) | ||
≥50% Resection | 29 (35) | 15 (27) | 14 (54) | 3.19 | 1.21–8.43 |
| |||||
Lateral Pharynx/Tonsil Resection | |||||
None to Parapharyngeal Fat Exposure | 73 (89) | 49 (88) | 24 (92) | ||
Exposed Carotid | 9 (11) | 7 (12) | 2 (8) | 0.58 | 0.11–3.02 |
| |||||
Soft Palate Resection | |||||
0–49% Resection | 77 (94) | 53 (95) | 24 (92) | ||
≥50% Resection | 5 (6) | 3 (5) | 2 (8) | NA | NA |
| |||||
Neck Dissection | |||||
None | 4 (5) | 3 (6) | 1 (4) | ||
Ipsilateral | 40 (49) | 31 (55) | 9 (35) | 0.87 | 0.08–9.43 |
Bilateral | 38 (46) | 22 (39) | 16 (61) | 2.18 | 0.21–22.95 |
| |||||
Neck Dissection | |||||
None or Ipsilateral | 44 (54) | 34 (61) | 10 (38) | ||
Bilateral | 38 (46) | 22 (39) | 16 (62) | 2.47 | 0.95–6.43 |
| |||||
CNX Resection | |||||
None | 81 (99) | 56 (100) | 25 (96) | ||
Performed | 1 (1) | 0 (0) | 1 (4) | NA | NA |
| |||||
CNXII Resection | |||||
None | 73 (89) | 51 (91) | 22 (85) | ||
Performed | 9 (11) | 5 (9) | 4 (15) | NA | NA |
| |||||
Lingual Nerve Resection | |||||
None | 71 (87) | 49 (88) | 22 (85) | ||
Performed | 11 (13) | 7 (12) | 4 (15) | 1.27 | 0.34–4.80 |
| |||||
Pterygoid Resection | |||||
None | 68 (83) | 44 (79) | 24 (92) | ||
Performed | 14 (17) | 12 (21) | 2 (8) | 0.31 | 0.06–1.48 |
| |||||
Type of Reconstruction | |||||
None, Local Flap, or Other | 75 (92) | 52 (93) | 23 (89) | ||
Regional or Free Flap | 7 (8) | 4 (7) | 3 (11) | NA | NA |
| |||||
Pharyngotomy | |||||
None | 47 (57) | 34 (61) | 13 (50) | ||
Performed | 35 (43) | 22 (39) | 13 (50) | 1.55 | 0.61–3.95 |
| |||||
p16 | |||||
Negative | 5 (6) | 4 (7) | 1 (4) | ||
Positive | 74 (94) | 51 (93) | 23 (96) | 1.80 | 0.19–17.05 |
Missing | 3 | ||||
| |||||
Adjuvant Therapy | |||||
None or Radiation Only | 37 (47) | 29 (54) | 8 (32) | ||
Chemoradiation Therapy | 42 (53) | 25 (46) | 17 (68) | 2.47 | 0.91–6.68 |
Missing | 3 | ||||
| |||||
Recurrence (Any) | |||||
None | 60 (73) | 43 (77) | 17 (65) | ||
Present | 22 (27) | 13 (23) | 9 (35) | 1.75 | 0.63–4.85 |
| |||||
Recurrence (Local or Regional) | |||||
None or Distant | 71 (87) | 48 (86) | 23 (89) | ||
Local or Regional | 11 (13) | 8 (14) | 3 (11) | 0.78 | 0.19–3.23 |
| |||||
Long-term Tracheostomy, 1 year follow-up | |||||
No | 77 (94) | 55 (98) | 22 (85) | ||
Yes | 5 (6) | 1 (2) | 4 (15) | 10.00 | 1.06–94.54 |
| |||||
Trismus, 1 year follow-up | |||||
No | 65 (79) | 46 (82) | 19 (73) | ||
Yes | 17 (21) | 10 (18) | 7 (27) | 1.70 | 0.56–5.11 |
OR = Odds Ratio
CI = Confidence Interval